EU Compassionate Use Programmes (CUPs)

  title={EU Compassionate Use Programmes (CUPs)},
  author={H{\'e}l{\`e}ne Sou},
  journal={Pharmaceutical Medicine},
  • Hélène Sou
  • Published 2012
  • Medicine, Business
  • Pharmaceutical Medicine
  • For some patients, compassionate use programmes (CUPs) are the only way to access promising medicinal products that are not yet authorized and for which clinical trials are either not available or in which these patients cannot participate. For such patients, the CUP benefits can be very important. Although an EU regulatory framework exists, there is no single, centralized EU-wide procedure for CUPs. Each Member State has its own procedures and CUP approvals are governed by national regulatory… CONTINUE READING
    11 Citations
    The Evolving Landscape of Early Access Programmes: Comparisons and Implications for Market Access.
    • PDF
    Medicines access programs to cancer medicines in Australia and New Zealand: An exploratory study.
    • 2
    • PDF